GÖTHENBURG, Sweden,
Sept. 25, 2018 /PRNewswire/ --
Capio today announces the notice of the Extraordinary General
Meeting (the "EGM") convened to resolve on the Board's proposal to
approve the sale of Capio France. The EGM will be held at
4.00 p.m. CEST on 18 October 2018. Capio also announces information
on the use of proceeds from the sale of Capio France, should the
EGM approve the transaction.
The proceeds from the transaction will be used partly to pay
down Capio Group debt and partly as a return of cash to
shareholders. The return of cash to shareholders is expected to be
between BSEK 1.8-2.1, equating to SEK
13-15 on a current per share basis.* This represents an
attractive cash return whilst ensuring an efficient capital
structure for Capio. Capio will have ample headroom for further
investments, driving digitalization, specialization and competence
development in the Nordics for the benefit of patients, employees
and the healthcare systems at large. Capio will also continue to
consolidate the fragmented Nordic markets.
An Extraordinary General Meeting will be convened after closing
of the transaction to approve an exact amount and the proposed
route to effect the cash distribution. Closing of the transaction
is expected to occur on 31 December
2018.
For further information on the Board's proposal to approve the
transaction and the reduction of Capio Group's debt including the
above mentioned cash return to shareholders, please refer to the
notice to the EGM, which will be communicated through a separate
announcement.
PJT Partners is acting as exclusive financial adviser,
Mannheimer Swartling and Allen & Overy are acting as legal
advisers and Fogel & Partners as communication adviser to Capio
on this transaction.
The Board of Directors of Capio AB (publ)
*Assumes 141,159,661 outstanding shares. Proceeds from the
sale of France are converted at a
EUR/SEK rate of 10.4213, as per the currency rate used in Capio's
Interim Report January – June 2018.
Potential transaction costs have been excluded.
Contact:
Henrik
Brehmer
SVP Group Communication & Public Affairs
Telephone: +46-761-11-34-14
E-mail: henrik.brehmer@capio.com
This is information that Capio AB (publ) is obliged to make
public pursuant to the EU Market Abuse Regulation. The information
was submitted for publication, through the agency of the contact
person set out above, at 08.00 a.m.
(CEST) on September 25,
2018.
Capio AB (publ) is a leading, pan-European healthcare provider
offering a broad range of high quality medical, surgical and
psychiatric healthcare services through its hospitals, specialist
clinics and primary care units. Capio operates in five countries;
Sweden, Norway, Denmark, France and Germany. In 2017, Capio's 13,314 employees
(average full-time equivalents) provided healthcare services during
5.1 million patient visits across the Group's facilities,
generating net sales of MSEK 15,327. Capio operates across three
geographic segments: Nordic (57% of Group net sales 2017),
France (35% of Group net sales
2017) and Germany (8% of Group net
sales 2017). For more information about Capio, please see
www.capio.com.
This information was brought to you by Cision
http://news.cision.com
http://news.cision.com/capio-ab/r/capio-announces-notice-of-extraordinary-general-meeting-and-information-on-the-use-of-proceeds-from-,c2626749
The following files are available for download:
http://mb.cision.com/Main/277/2626749/915060.pdf
|
Press release
(PDF)
|